University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 15 of 24
Constraint-induced Movement Therapy to Improve Gait and Mobility of People With Chronic Stroke
NCT03114046
Peripheral Vision Training Study
NCT03141164
Carbon Fiber Implants
NCT03382041
Impact of Exercise in Parkinson's Disease
NCT03495193
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B
NCT03567551
Nitrite Infusion in Islet Cell Transplantation
NCT03544242
Southeastern Collaboration to Improve Blood Pressure Control
NCT02866669
Race, Natriuretic Peptides and Physiological Perturbations
NCT03070184
Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations
NCT03256799
The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor
NCT03085485
The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges
NCT03468998
Racial Differences in the Natriuretic Peptide Response to Glucose Challenge
NCT03072602
Precision High-Intensity Training Through Epigenetics (PHITE)
NCT03380923
Advanced Virtual Exercise Environment Device for Use by Persons With Physical Disabilities
NCT02990507
Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI
NCT03734289
From Clinic to Community: An Information and Communication Technology (ICT) Home-Based Exercise Training System for Translating Clinical Findings
NCT03108950
Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions
NCT02903446
PTC Study to Evaluate Ataluren in Combination With Ivacaftor
NCT03256968
Rare Diseases Clinical Research Network: Neurophysiological Correlates
NCT03077308
Acute Kidney Injury in Patients With Sickle Cell Disease
NCT03105271
In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence
NCT02938403
A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis
NCT03022617
Partnership Optimizes Weight Management in Primary Care
NCT02959021
Virtual Reality by Mobile Phone: Improving Child Pedestrian Safety
NCT02948400
Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta
NCT03713710
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
NCT02925923
Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder
NCT02995967
Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma
NCT03168919
Harvest for Health in Older Cancer Survivors
NCT02985411
Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited Mobility
NCT03029182
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
NCT02837042
Speed of Processing Training in Adults With HIV
NCT02758093
Novel Methods for Ascertainment of Gout Flares -A Pilot Study
NCT02855437
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
NCT02888171
The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment
NCT02339220
POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability
NCT03139760
Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial
NCT02915549
Diet Composition and Cardiometabolic Risk Reduction in Adults With SCI
NCT02630524
Assessment of the Efficacy of the Aerodentis System
NCT03421886
Smart Telehealth Exercise Intervention to Reduce COPD Readmissions
NCT03089853
Effects of Botanical Microglia Modulators in Gulf War Illness
NCT02909686
Impact of Pre-operative Steroids on Adrenal Insufficiency
NCT02956707
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
NCT02848222
Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section
NCT03098420
Bupivacaine With Epidural Volume Extension
NCT03110003
Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
NCT02835833
Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea
NCT03109418
Ultrasound Assessment of Volume in Patients on Continuous Dialysis
NCT03194750
Pharmacogenomic Profiling of Pediatric Patients
NCT02770339
Treatment Outcomes of ReACT for PNES
NCT02801136
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.